Swiss National Bank Meira G Tx Holdings PLC Transaction History

Swiss National Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$6.8 - $14.23 $69,360 - $145,146	10,200 Added 19.39%	62,800 $475,000
Q1 2022 May 09, 2022	BUY	$13.42 - $23.38 $50,996 - $88,844	3,800 Added 7.79%	52,600 $729,000
Q4 2021 Feb 08, 2022	BUY	$12.78 - $23.74 $12,780 - $23,740	1,000 Added 2.09%	48,800 $1.16 Million
Q2 2021 Aug 06, 2021	SELL	$12.85 - $16.2 $20,560 - $25,920	-1,600 Reduced 3.24%	47,800 $741,000
Q4 2020 Feb 05, 2021	BUY	$12.4 - $17.6 $198,400 - $281,600	16,000 Added 47.9%	49,400 $748,000
Q2 2020 Aug 05, 2020	BUY	$11.79 - $15.97 $63,665 - $86,238	5,400 Added 19.29%	33,400 $418,000
Q4 2019 Feb 06, 2020	BUY	$13.91 - $21.48 $44,512 - $68,736	3,200 Added 12.9%	28,000 $561,000
Q2 2019 Aug 02, 2019	BUY	$17.38 - $26.88 $431,024 - $666,624	24,800 New	24,800 $667,000

39.7M

24.2K

30.7K

Ticker MGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,010,700
Market Cap $192M
Description
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.